pseudohypericin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
pseudohypericin: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murali, M | 2 |
| Gowtham, HG | 2 |
| Shilpa, N | 2 |
| Krishnappa, HKN | 2 |
| Ledesma, AE | 2 |
| Jain, AS | 2 |
| Shati, AA | 2 |
| Alfaifi, MY | 2 |
| Elbehairi, SEI | 2 |
| Achar, RR | 2 |
| Silina, E | 2 |
| Stupin, V | 2 |
| Ortega-Castro, J | 2 |
| Frau, J | 2 |
| Flores-Holguín, N | 2 |
| Amruthesh, KN | 2 |
| Shivamallu, C | 2 |
| Kollur, SP | 2 |
| Glossman-Mitnik, D | 2 |
1 other study available for pseudohypericin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |